Dhaval Shah
Infectious Disease · Las Vegas, NVNPI 1194711358
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $19,480 of the $27,023 with a category attached, or 72.1%. Paratek Pharmaceuticals, Inc. accounts for 60.6% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $17,580 and has fallen 99.7% since, to $51 in 2024. Among infectious disease clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $188.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$16K
- Cumberland Pharmaceuticals, Inc.$4K
- Merck$4K
- Insmed, Inc.$499
- Viiv Healthcare Company$479
- Melinta Therapeutics, LLC$305
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$19,48072%
- Travel & lodging$4,13515%
- Food & beverage$3,38513%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 33 | $16,369 |
| Cumberland Pharmaceuticals, Inc. | 10 | $4,236 |
| Merck | 14 | $3,889 |
| Insmed, Inc. | 4 | $499 |
| Viiv Healthcare Company | 15 | $479 |
| Melinta Therapeutics, LLC | 10 | $305 |
| AbbVie(2 entities) | 16 | $298 |
| Astellas Pharma US Inc | 9 | $158 |
| Gilead | 6 | $131 |
| Philips North America LLC | 7 | $120 |
| Sunovion Pharmaceuticals Inc. | 1 | $119 |
| Boston Scientific | 1 | $100 |
| Johnson & Johnson | 6 | $88 |
| La Jolla Pharmaceutical Company | 3 | $75 |
| Theratechnologies Inc. | 3 | $58 |
| Smith+Nephew | 1 | $37 |
| Leadiant Biosciences, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,023 in reported general payments places this provider in the 90th percentile of 65 infectious disease providers in Nevada.
Other infectious disease in Las Vegas
- Alireza FarabiLas Vegas$588K
- Dhiresh JoshiLas Vegas$96K
- Shaker ItaniLas Vegas$52K
- Alka RebentishLas Vegas$23K
- Ronald ShockleyLas Vegas$13K
- Chukwudum UcheLas Vegas$13K
- John OreillyLas Vegas$8K
- Li-Chien ChenLas Vegas$8K
- Naima ZaheerLas Vegas$7K
- Ricardo Cedeno-MendozaLas Vegas$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.